Tufts Center for the Study of Drug Development
Tufts University
75 Kneeland Street
Suite 1100
Boston, MA 02111
![]() | Christopher.Milne@tufts.edu |
Research Focus: Identifying and evaluating problems and solutions affecting innovation efficiency and the globalization of R&D; tracking the progress of incentive programs for special patient populations (pediatric and orphan diseases) and neglected diseases of the developing world; assessing the impact of emerging regulatory and reimbursement trends, such as risk evaluation and mitigation strategies (REMS) in the US and Europe’s risk management plan (EU-RMP) program, comparative effectiveness, and risk-sharing arrangements; and, updating developments in new science and policy initiatives, such as personalized medicine, FDA’s Regulatory Science initiative, the EU’s Innovative Medicines Initiative, and Translational Medicine.